Breaking News Instant updates and real-time market news.

CRSP

CRISPR Therapeutics

$21.24

0.49 (2.36%)

16:40
03/20/17
03/20
16:40
03/20/17
16:40

CRISPR Therapeutics says CFO Becker to go on family leave

CRISPR Therapeutics disclosed in a regulatory filing that effective March 21, Marc Becker, Senior Vice President and CFO of CRISPR Therapeutics, who has served as the company's CFO since February 2016, will go on a family and medical leave of absence. The company currently plans to provide an update on the status of Mr. Becker's leave of absence prior to the end of the second quarter. During Mr. Becker's leave of absence and effective March 21, Samarth Kulkarni, Ph.D., the company's Chief Business Officer will serve as the company's acting principal financial officer and Michael Esposito, the Company's Senior Director, Controller, will serve as the company's acting principal accounting officer.

CRSP CRISPR Therapeutics
$21.24

0.49 (2.36%)

11/14/16
11/14/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Conagra Brands (CAG) initiated with a Neutral at UBS. 2. CRISPR Therapeutics (CRSP) initiated with an Overweight at Barclays, an Overweight at Piper Jaffray, and a Buy at Guggenheim. 3. Forterra (FRTA) initiated with a Neutral at Goldman, an Outperform at RBC Capital, a Buy at Citi, an Outperform at Oppenheimer, a Hold at Deutsche Bank, and a Buy at SunTrust. 4. iRhythm Technologies (IRTC) initiated with an Overweight at JPMorgan, a Buy at BTIG, a Buy at Canaccord, and an Overweight at Morgan Stanley. 5. Teva (TEVA) reinstated with an Equal Weight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/15/16
SBSH
11/15/16
INITIATION
Target $19
SBSH
Neutral
CRISPR Therapeutics initiated with a Neutral at Citi
Citi analyst Yigal Nochomovitz started CRISPR Therapeutics with a Neutral rating and $19 price target. The risk/reward is balanced with the stock up 25% since the initial public offering, Nochomovitz tells investors in a research note. The analyst sees "no clear winner" in the gene editing patent debate.
02/15/17
JEFF
02/15/17
NO CHANGE
JEFF
Patent ruling best case for Editas Medicine, says Jefferies
Jefferies analyst Gena Wang views the United States Patent and Trademark Office's judgment of "no interference-in-fact" for the CRISPR/Cas9 interference motion phase as the "best case" for Editas Medicine (EDIT), Broad Institute's licensee. The analyst sees three choices for The University of California, which has CRISPR Therapeutics (CRSP) and Intellia Therapeutics (NTLA) as licensees: Appeal, seek second interference, or discuss a settlement. Wang sees cross-licensing as the likely eventual path taken by both parties. CRISPR and Intellia could license from Editas the use of CRISPR in eukaryotic cells, while Editas could license from the two companies the use of single guide and tracrRNA, the analyst tells investors in a research note. She believes a royalty could be in the mid-single-digit range. Shares of Editas are up 33% to $24.99 in afternoon while CRISPR is down 13% to $15.05 and Intellia is down 11% to $12.26.
02/16/17
PIPR
02/16/17
NO CHANGE
Target $21
PIPR
Overweight
Piper's Schimmer calls CRISPR selloff 'major overreaction'
Piper Jaffray analyst Joshua Schimmer views yesterday's selloff in shares of CRISPR Therapeutics (CRSP) as a "major overreaction." The stock closed yesterday down 8%, or $1.36, to $15.90 after the patent office did not allow the patent interference with UC Berkeley versus Broad Institute over a Crispr/Cas-9 patent. Now that it's deemed patentable, CRISPR will move forward to get its own claims issued and likely move towards a second interference, Schimmer tells investors in a research note. CRISPER and Intellia Therapeutics (NTLA) are essentially litigation partners against the Broad, and now have the chance to win by knocking out Editas Medicine's (EDIT) single-guide tracr patent or by showing it was the first to invent and reduce to practice the application in eukaryotes, the analyst contends. Schimmer says he can't understand why Editas' valuation is higher than CRISPR's. He believes it should be the opposite. The analyst keeps an Overweight rating on CRISPR with a $21 price target.

TODAY'S FREE FLY STORIES

GIII

G-III Apparel

$22.92

-0.04 (-0.17%)

20:25
03/24/17
03/24
20:25
03/24/17
20:25
Earnings
Notable companies reporting before Monday's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

FOX

21st Century Fox

$30.88

0.13 (0.42%)

, FOXA

21st Century Fox

$31.52

0.19 (0.61%)

18:47
03/24/17
03/24
18:47
03/24/17
18:47
Periodicals
21st Century Fox, Sky deal to be weighed by EU regulators, Bloomberg says »

21st Century Fox's…

FOX

21st Century Fox

$30.88

0.13 (0.42%)

FOXA

21st Century Fox

$31.52

0.19 (0.61%)

SKYAY

Sky

$48.36

-0.826 (-1.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

UPS

UPS

$105.05

-0.6 (-0.57%)

18:19
03/24/17
03/24
18:19
03/24/17
18:19
Periodicals
UPS found liable for illegally shipping untaxed cigarettes in NY, Reuters says »

U.S. District Judge…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

  • 29

    Mar

  • 30

    Mar

TCBI

Texas Capital

$80.25

0.3 (0.38%)

, ENH

Endurance Specialty

$92.97

0.1 (0.11%)

18:13
03/24/17
03/24
18:13
03/24/17
18:13
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

TCBI

Texas Capital

$80.25

0.3 (0.38%)

ENH

Endurance Specialty

$92.97

0.1 (0.11%)

DSW

DSW

$19.27

0.13 (0.68%)

WETF

WisdomTree

$8.59

0.03 (0.35%)

SCAI

Surgical Care Affiliates

MIK

Michaels

$21.96

0.17 (0.78%)

UNH

UnitedHealth

$165.00

-0.29 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

AAPL

Apple

$140.64

-0.28 (-0.20%)

17:42
03/24/17
03/24
17:42
03/24/17
17:42
Periodicals
Apple can make new highs on iPhone 8 launch, dividend hike, Barron's says »

Apple's share price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFT

Weatherford

$5.89

0.02 (0.34%)

, SLB

Schlumberger

$76.96

-0.71 (-0.91%)

17:37
03/24/17
03/24
17:37
03/24/17
17:37
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Weatherford…

WFT

Weatherford

$5.89

0.02 (0.34%)

SLB

Schlumberger

$76.96

-0.71 (-0.91%)

MIK

Michaels

$21.96

0.17 (0.78%)

DSW

DSW

$19.27

0.13 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Apr

  • 01

    May

FSNN

Fusion Telecommunications

$1.74

0.23 (15.23%)

17:34
03/24/17
03/24
17:34
03/24/17
17:34
Hot Stocks
Breaking Hot Stocks news story on Fusion Telecommunications »

Apptix reports 14.4%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

MIK

Michaels

$21.96

0.17 (0.78%)

, WETF

WisdomTree

$8.59

0.03 (0.35%)

17:24
03/24/17
03/24
17:24
03/24/17
17:24
Hot Stocks
Breaking Hot Stocks news story on Michaels, WisdomTree »

Michaels to replace…

MIK

Michaels

$21.96

0.17 (0.78%)

WETF

WisdomTree

$8.59

0.03 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WETF

WisdomTree

$8.59

0.03 (0.35%)

, SCAI

Surgical Care Affiliates

17:23
03/24/17
03/24
17:23
03/24/17
17:23
Hot Stocks
WisdomTree to replace Surgical Care Affiliates in S&P 600 at open on March 29 »

S&P 100 & 500…

WETF

WisdomTree

$8.59

0.03 (0.35%)

SCAI

Surgical Care Affiliates

UNH

UnitedHealth

$165.00

-0.29 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

DSW

DSW

$19.27

0.13 (0.68%)

, TCBI

Texas Capital

$80.25

0.3 (0.38%)

17:21
03/24/17
03/24
17:21
03/24/17
17:21
Hot Stocks
Breaking Hot Stocks news story on DSW, Texas Capital »

DSW to replace Texas…

DSW

DSW

$19.27

0.13 (0.68%)

TCBI

Texas Capital

$80.25

0.3 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCBI

Texas Capital

$80.25

0.3 (0.38%)

, ENH

Endurance Specialty

$92.97

0.1 (0.11%)

17:20
03/24/17
03/24
17:20
03/24/17
17:20
Hot Stocks
Texas Capital to replace Endurance Specialty in S&P 400 at open on March 29 »

SOMPO Holdings is…

TCBI

Texas Capital

$80.25

0.3 (0.38%)

ENH

Endurance Specialty

$92.97

0.1 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHMT

Chemtura

17:20
03/24/17
03/24
17:20
03/24/17
17:20
Hot Stocks
Chemtura raises prices for petroleum additives products »

Chemtura Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADM

Archer Daniels

$45.58

-0.03 (-0.07%)

17:17
03/24/17
03/24
17:17
03/24/17
17:17
Hot Stocks
Archer Daniels shuts down Decatur corn plant, sees small negative Q1 impact »

Archer Daniels Midland…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

RT

Ruby Tuesday

$2.45

-0.05 (-2.00%)

17:17
03/24/17
03/24
17:17
03/24/17
17:17
Hot Stocks
Leon Capital reports 9.5% stake in Ruby Tuesday »

Leon Capital, which owns…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Apr

LAKE

Lakeland Industries

$10.00

-0.0443 (-0.44%)

17:15
03/24/17
03/24
17:15
03/24/17
17:15
Syndicate
Breaking Syndicate news story on Lakeland Industries »

Lakeland Industries files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMTC

Semtech

$34.35

0.5 (1.48%)

17:14
03/24/17
03/24
17:14
03/24/17
17:14
Hot Stocks
Semtech CEO Mohan Maheswaran enters 10b5-1 trading plan »

On March 23, Mohan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

SCOR

comScore

$21.36

-0.04 (-0.19%)

17:06
03/24/17
03/24
17:06
03/24/17
17:06
Hot Stocks
comScore to delay filing annual report on Form 10-K »

As previously disclosed,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$81.23

-0.63 (-0.77%)

17:02
03/24/17
03/24
17:02
03/24/17
17:02
Hot Stocks
Exxon Mobil urges holders to reject mini-tender offer by TRC Capital »

Exxon Mobil announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

USCR

U.S. Concrete

$60.80

-5.9 (-8.85%)

16:59
03/24/17
03/24
16:59
03/24/17
16:59
Hot Stocks
U.S. Concrete announces resignation of CFO Joseph Tusa »

U.S. Concrete announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DG

Dollar General

$69.48

0.58 (0.84%)

16:47
03/24/17
03/24
16:47
03/24/17
16:47
Syndicate
Breaking Syndicate news story on Dollar General »

Dollar General files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Apr

SLB

Schlumberger

$76.96

-0.71 (-0.91%)

, WFT

Weatherford

$5.89

0.02 (0.34%)

16:47
03/24/17
03/24
16:47
03/24/17
16:47
Hot Stocks
Schlumberger, Weatherford to form OneStim joint venture »

Schlumberger (SLB) and…

SLB

Schlumberger

$76.96

-0.71 (-0.91%)

WFT

Weatherford

$5.89

0.02 (0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Apr

  • 01

    May

AAPL

Apple

$140.66

-0.2592 (-0.18%)

, GOOGL

Alphabet Class A

$835.14

-4.51 (-0.54%)

16:43
03/24/17
03/24
16:43
03/24/17
16:43
General news
On The Fly: Stocks end week lower as health care bill vote ends up scrapped »

Stocks ended the week…

AAPL

Apple

$140.66

-0.2592 (-0.18%)

GOOGL

Alphabet Class A

$835.14

-4.51 (-0.54%)

GOOG

Alphabet

$814.95

-2.63 (-0.32%)

DIS

Disney

$112.14

-0.1 (-0.09%)

SHLD

Sears

$8.50

0.31 (3.79%)

F

Ford

$11.62

-0.05 (-0.43%)

JPM

JPMorgan

$87.29

-0.1 (-0.11%)

WFC

Wells Fargo

$55.83

0.58 (1.05%)

GS

Goldman Sachs

$228.41

-3.49 (-1.51%)

C

Citi

$58.07

0.02 (0.03%)

BAC

Bank of America

$23.12

0.05 (0.22%)

GE

General Electric

$29.72

0.1 (0.34%)

T

AT&T

$41.68

0.03 (0.07%)

VZ

Verizon

$49.68

0.04 (0.08%)

JNJ

Johnson & Johnson

$125.48

-0.42 (-0.33%)

PEP

PepsiCo

$112.12

0.34 (0.30%)

WMT

Wal-Mart

$69.61

-0.25 (-0.36%)

DISH

DISH

$61.99

0.11 (0.18%)

SBUX

Starbucks

$56.81

0.96 (1.72%)

GM

General Motors

$34.56

0.3 (0.88%)

TM

Toyota

$111.36

0.85 (0.77%)

MSFT

Microsoft

$64.98

0.11 (0.17%)

KO

Coca-Cola

$42.12

-0.05 (-0.12%)

PG

Procter & Gamble

$90.57

-0.2 (-0.22%)

CHTR

Charter

$325.35

1.73 (0.53%)

TRP

TransCanada

$46.21

-0.05 (-0.11%)

PPG

PPG

$103.79

-0.83 (-0.79%)

AKZOY

AkzoNobel

$27.65

-0.234 (-0.84%)

FDX

FedEx

$188.12

-1.07 (-0.57%)

DLTH

Duluth Holdings

$22.76

0.39 (1.74%)

PVH

PVH Corp.

$100.94

2.39 (2.43%)

FIVE

Five Below

$42.62

0.37 (0.88%)

MU

Micron

$28.43

1.96 (7.40%)

GIS

General Mills

$59.16

-0.21 (-0.35%)

CSIQ

Canadian Solar

$11.15

-0.485 (-4.17%)

NKE

Nike

$56.36

0.99 (1.79%)

SLW

Silver Wheaton

$20.54

-0.07 (-0.34%)

GME

GameStop

$20.70

-3.26 (-13.61%)

FINL

Finish Line

$12.93

-3.13 (-19.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Mar

  • 27

    Mar

  • 27

    Mar

  • 27

    Mar

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

  • 30

    Mar

  • 30

    Mar

  • 06

    Apr

  • 13

    Apr

  • 13

    Apr

  • 13

    Apr

  • 18

    Apr

  • 26

    Apr

  • 27

    Apr

  • 02

    May

  • 09

    May

  • 09

    May

  • 09

    May

  • 22

    May

  • 24

    May

  • 02

    Jun

  • 06

    Jun

  • 20

    Jun

  • 22

    Jun

  • 13

    Jul

  • 14

    Jul

  • 25

    Jul

  • 12

    Oct

  • 12

    Oct

  • 15

    Jan

  • 13

    Apr

  • 13

    Jul

  • 12

    Oct

CI

Cigna

$145.82

-3.36 (-2.25%)

16:35
03/24/17
03/24
16:35
03/24/17
16:35
Hot Stocks
Cigna CEO David Cordani adopts 10b5-1 trading plan »

On March 15, David…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENT

Global Eagle

$2.92

-0.16 (-5.19%)

16:32
03/24/17
03/24
16:32
03/24/17
16:32
Hot Stocks
Global Eagle receives notice of non-compliance from Nasdaq »

On March 20, Global Eagle…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Apr

16:31
03/24/17
03/24
16:31
03/24/17
16:31
Options
Preliminary option volume of 17.5M today »

Preliminary option volume…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.